Behavioral Science Banner Maps Future Of GSK’s Over The Counter Business
This article was originally published in The Pink Sheet Daily
Executive Summary
Smoking cessation, weight-loss products grouped in new category that may one day include OTC statins a la Mevacor.
You may also be interested in...
FDA Advisors Again Deny Lovastatin OTC Status
Merck fails in third attempt to convince panel consumers can make an appropriate self-selection decision regarding Mevacor Daily.
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement